Fol. Biol. 2014, 60, 187-191
https://doi.org/10.14712/fb2014060040187
The Effect of MDMA-Induced Anxiety on Neuronal Apoptosis in Adult Male Rats' Hippocampus
References
1. , A., Pasbakhsh, P., Akbari, M., Barbarestani, M., Ghahremani, M., Shokrgozar, M., et al. (2009) dual effects of 3,4-methylenedioxymethamphetamine (ecstasy) on survival and apoptosis of primary hippocampal neurons. Neural Regen. Res. 4, 1068-1072.
2. , S. K., Bhattacharya, A., Ghosal, S. (1998) Anxiogenic activity of methylenedioxymethamphetamine (Ecstasy): an experimental study. Biogenic Amines 14, 217-237.
3. , J. P., Carmo, H., Remião, F., Bastos, M. L., Meisel, A., Carvalho, F. (2009) Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Mol. Neurobiol. 39, 210-271.
<https://doi.org/10.1007/s12035-009-8064-1>
4. , K. O., Kim, S. K., Rhee, G. S., Kwack, S. J., Cho, D. H., Sung, K. W., Kim, S. y. (2007) Chronic 3,4-methylenedioxymethamphetamine treatment suppresses cell proliferation in the adult mouse dentate gyrus. Eur. J. Pharmacol. 566, 120-123.
<https://doi.org/10.1016/j.ejphar.2007.04.008>
5. , K. O., Rhee, G., Kwack, S., Chung, S., Kim, S. (2008) developmental exposure to 3,4-methylenedioxymethamphetamine results in downregulation of neurogenesis in the adult mouse hippocampus. Neuroscience 154, 1034-1041.
<https://doi.org/10.1016/j.neuroscience.2008.04.040>
6. , J. C., Sumnall, H. R. (2003) Altered states: the clinical effects of Ecstasy. Pharmacol. Ther. 98, 35-58.
<https://doi.org/10.1016/S0163-7258(03)00003-2>
7. , W. E., Ciullo, J. R., Wakabayashi, K. T., Garza, R. (2008) A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse. Neuroscience 151, 533-543.
<https://doi.org/10.1016/j.neuroscience.2007.11.007>
8. , V., Stankevicius, D., Ribeiro, A., Pinheiro, M., Rodrigues-Costa, E., Florio, J., Lapachinske, S. F., Moreau, R. L. M., Palermo-Neto, J. (2011) Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MdMA-ecstasy) in anxiety-like responses in mice. Braz. J. Med. Biol. Res. 44, 428-437.
9. , A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., Colado, M. I. (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MdMA, “ecstasy”). Pharmacol. Rev. 55, 463-508.
<https://doi.org/10.1124/pr.55.3.3>
10. , C. G., Morley, K. C., Li, K. M., Hunt, G. E., McGregor, I. S. (2002) Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion. Eur. J. Pharmacol. 446, 89-96.
<https://doi.org/10.1016/S0014-2999(02)01820-4>
11. , S. L., McBlane, J. W. (1993) An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs. J. Pharmacol. Toxicol. Methods 29, 129-138.
<https://doi.org/10.1016/1056-8719(93)90063-K>
12. , V., Domínguez-Escrib, L., Barcia, J. A., Rosel, J. F., Romero, F. J., Garcia-Verdugo, J. M., Canales, J. J. (2006) Binge administration of 3,4-methylenedioxymethamphetamine (“ecstasy”) impairs the survival of neural precursors in adult rat dentate gyrus. Neuropharmacology 51, 967-973.
<https://doi.org/10.1016/j.neuropharm.2006.06.019>
13. , Y. J., Pawlak, C. R., Guo, L., Schwarting, R. K. W. (2004) Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat. Behav. Brain Res. 149, 135-144.
<https://doi.org/10.1016/S0166-4328(03)00220-1>
14. , M., Sadeghi, Y., Hosseini, A. (2006) Estimation of astrocyte number in different subfield of rat hippocampus. Pak. J. Biol. Sci. 9, 1595-1597.
<https://doi.org/10.3923/pjbs.2006.1595.1597>
15. , M., Nickmahzar, E., Babakordi, F. (2013a) The effect of Ginkgo biloba extract on scopolamine-induced apoptosis in the hippocampus of rats. Anat. Sci. Int. 17, 1-6.
16. , M., Nikmahzar, E. G., Babakordi, F., Khosravi, M., Seid-Hosseini, F. (2013b) Ecstasy, anxiety and rat hippocampal astrocytes. Eur. J. Anat. 17, 23-28.
17. , A., Jordà, E. G., Verdaguer, E., Pubill, D., Sureda, F. X., Canudas, A. M., Escubedoa, E., Camarasaa, J., Caminsa, A., Pallàs, M. (2004) Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells. Toxicol. Appl. Pharmacol. 196, 223-234.
<https://doi.org/10.1016/j.taap.2003.12.017>
18. , H. (2001) The pharmacology and toxicology of ‘ecstasy’ (MdMA) and related drugs. CMAJ 165, 917-928.
19. , K. G., Tuvnes, F. A., Steffenach, H. A., Murison, R., Moser, E. I., Moser, M. B. (2002) Reduced fear expression after lesions of the ventral hippocampus. Proc. Natl. Acad. Sci. USA 99, 10825-10830.
<https://doi.org/10.1073/pnas.152112399>
20. , W. D. (1992) Normal anatomy and neurophysiology of the hippocampal formation. J. Clin. Neurophysiol. 9, 253-263.
<https://doi.org/10.1097/00004691-199204010-00006>
21. , G., Martin, S. J. (2005) Caspase-independent cell death. Nat. Med. 11, 725-730.
<https://doi.org/10.1038/nm1263>
22. , H. Q., Burden, P. M., Christie, M. J., Johnston, G. A. R. (1999) The anxiogenic-like and anxiolytic-like effects of MdMA on mice in the elevated plus-maze: a comparison with amphetamine. Pharmacol. Biochem. Behav. 62, 403-408.
<https://doi.org/10.1016/S0091-3057(98)00191-9>
23. , S. B., Deacon, R. M. J., Rawlins, J. N. P., Bannerman, D. M. (2004) Amygdala and ventral hippocampus contribute differentially to mechanisms of fear and anxiety. Behav. Neurosci. 118, 63-78.
<https://doi.org/10.1037/0735-7044.118.1.63>
24. , J. F., Maldonado, E. (2002) Acute and subchronic effects of MDMA. Prog. Neuropsychopharmacol. Biol. Psychiatry 26, 1151-1154.
<https://doi.org/10.1016/S0278-5846(02)00250-6>
25. , T., Votava, M., Bubenikova, V., Horacek, J. (2005) Increased sensitivity to the acute effects of MDMA. Physiol. Behav. 86, 546-553.
<https://doi.org/10.1016/j.physbeh.2005.08.043>
26. , S., Chopin, P., File, S. E., Briley, M. (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14, 149-167.
<https://doi.org/10.1016/0165-0270(85)90031-7>
27. , I., Cerretani, D., Fiore, C., Bello, S., Centini, F., D’Errico, S., Fiaschi, A. I., Giorgi, G., Neri, M., Pomara, C., Turillazzi, E., Fineschi, V. (2010) Enzymatic-non- enzymatic cellular antioxidant defense systems response and immunohistochemical detection of MdMA, VMAT2, HSP70, and apoptosis as biomarkers for MdMA (ecstasy) neurotoxicity. J. Neurosci. Res. 88, 905-916.
<https://doi.org/10.1002/jnr.22245>
28. Rodgers, R., Cole, J.(1994) The elevated plus-maze: pharmacology, methodology and ethology. In: Ethology and Psychopharmacology, eds. Coopper S. J., Hendrie C. A., pp. 9-43, John Wiley and Sons Ltd., New York
29. , D. L., Van Hoesen, G. W. (1987) The hippocampal formation of the primate brain. A review of some comparative aspects of cytoarchitecture and connections. Cereb. Cortex 6, 345-456.
<https://doi.org/10.1007/978-1-4615-6616-8_9>
30. , H. (1983) Evolutionary trends in limbic structures. Neurosci. Biobehav. Rev. 7, 367-374.
<https://doi.org/10.1016/0149-7634(83)90041-6>
31. , M. L., Knudsen, G. M., Aznar, S. (2004) No effect of MdMA (ecstasy) on cell death and 5-HT2A receptor density in organotypic rat hippocampal cultures. Neurosci. Lett. 362, 6-9.
<https://doi.org/10.1016/j.neulet.2004.01.051>
32. , D. (1985) Animal models for the study of anti-anxiety agents: a review. Neurosci. Biobehav. Rev. 9, 203-222.
<https://doi.org/10.1016/0149-7634(85)90046-6>
33. , X., Li, J., Zhu, S. P. (2007) Neuron apoptosis induced by 3,4-methylenedioxy methamphetamine and the expression of caspase-3. West China Journal of Pharmaceutical Sciences 22, 511.
34. , X., Zhu, S. P., Kuang, W. H., Li, J., Sun, X., Huang, M. S., Sun, X. (2009) Neuron apoptosis induced by 3,4-methylenedioxy methamphetamine and expression of apoptosis-related factors in rat brain. Journal of Sichuan University. Medical science edition 40, 1000-1002, 1037.
